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Serial femtosecond X-ray crystallography (SFX) using an X-ray free electron laser (XFEL) is a recent advancement in
structural biology for solving crystal structures of challenging membrane proteins, including G-protein coupled receptors
(GPCRs), which often only produce microcrystals. An XFEL delivers highly intense X-ray pulses of femtosecond duration
short enough to enable the collection of single diffraction images before significant radiation damage to crystals sets in.
Here we report the deposition of the XFEL data and provide further details on crystallization, XFEL data collection and
analysis, structure determination, and the validation of the structural model. The rhodopsin-arrestin crystal structure
solved with SFX represents the first near-atomic resolution structure of a GPCR-arrestin complex, provides structural
insights into understanding of arrestin-mediated GPCR signaling, and demonstrates the great potential of this SFX-XFEL
technology for accelerating crystal structure determination of challenging proteins and protein complexes.
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Background and Summary
Serial femtosecond X-ray crystallography (SFX) is an innovative development for protein structure
determination, which uses X-ray free electron lasers (XFELs) as a radiation source to elicit diffraction
from crystals1. An XFEL beam delivers extremely intense X-ray laser pulses that allow high resolution
diffraction data collection from crystals of micrometer to nanometer size in random orientations. XFEL
pulses of shorter than fifty femtosecond duration diffract protein crystals and terminate before significant
radiation damage occurs in the protein, thus enabling data collection with reduced radiation damage
using a dose higher than tolerable for cryogenically cooled crystals2,3. SFX has a high potential for
structure determination of challenging proteins such as GPCRs and other membrane proteins that often
don’t form crystals of sufficient size for synchrotron data collection4. Thus, SFX represents an important
advancement in protein crystallography.
GPCRs comprise a large family of membrane proteins that are involved in many key signal
transduction pathways in human physiology, and are targeted by approximately 40% of all approved
pharmaceutical drugs5–7. Crystal structure determination of GPCRs and their complexes has been
challenging due to their low expression levels, low stability in detergent micelles, and their recalcitrance to
crystallization. In recent years, reports have been increasingly emerging about the successful structural
determination by X-ray crystallography, owing to the development and the application of new techniques
including protein fusion and the lipidic cubic phase (LCP) crystallization by which protein
crystallogenesis occurs in a membrane-mimicking mesophase environment8. Crystallographic studies
of GPCRs, nevertheless, remain a significant challenge because even in LCP many GPCRs produce
micrometer-sized crystals that are too small for study at synchrotron sources.
In this paper, we report the deposition of the XFEL data for the recently published SFX structure
determination of a rhodopsin-arrestin complex9 (Data Citation 1) as well as further details of
crystallization, data collection, structure solution and validation. This rhodopsin-arrestin crystal structure
is the first GPCR-arrestin complex structure that reveals the mechanism of GPCR recruitment of arrestin
for desensitizing G protein signaling and initiating the arrestin-mediated signaling cascade.
Methods
Crystallization of rhodopsin-arrestin complex
Human rhodopsin and mouse visual arrestin-1 were used in our study. A T4 lysozyme (T4L)-rhodopsin-
arrestin fusion protein was designed to form a stabilized rhodopsin-arrestin complex for crystallization
with LCP technology. The fusion protein contains an N-terminal T4L (residues 1–162) and the
full-length human rhodopsin (residues 1–348), which is followed by a 15-amino acid linker
(AAAGSAGSAGSAGSA) and a mutant mouse visual arrestin (L374A, V375A, F376A, residues 10–392).
This fused protein was expressed in HEK293S cells using a tetracycline-inducible expression vector with
an N-terminal His8-MBP-MBP expression tag and a 3C protease cleavage site. The fusion protein was
extracted from the cell membrane using an extraction buffer containing 0.5%(w/v) n-dodecyl-β-D-
maltopyranoside (DDM, Anatrace) and 0.1% (w/v) cholesteryl hemisuccinate (CHS, Anatrace), and
purified by amylose affinity chromatography. The protein sample was further purified using size
exclusion chromatography and was concentrated to about 30 mg/ml for crystallization. All-trans-retinal
at a molar ratio of 5 retinal:1 protein was added prior to crystallization.
LCP crystallization of T4L-rhodopsin-arrestin fusion protein was performed using the
monoacylglycerol (MAG) monopalmitolein (9.7 MAG, Nu Chek) containing 10% (w/w) cholesterol as
the host lipid. Monoolein (9.9 MAG, Nu Chek), the most widely used host lipid for GPCR crystal growth,
was first used as the host lipid for crystallization of the fusion protein with different concentrations of
PEG 400 in combination with the StockOption Salt kit (Hampton Research) at various pH levels, but did
not support crystal growth of the T4L-rhodopsin-arrestin complex. We thus tested several alternative
lipids including 6.9 MAG (Nu Chek), 7.9 MAG (Anatrace), 9.7 MAG, 8.7 MAG (Anatrace) and 10.7
MAG (Nu Chek). Of all the lipids tested, only 9.7 MAG reproducibly facilitated the crystallization of the
T4L-rhodopsin-arrestin complex. Figure 1a shows the temperature-composition phase diagram for 9.7
MAG constructed based on small- and wide-angle X-ray scattering measurements made in the heating
direction10,11. The maximum water-carrying capacity of 9.7 MAG is close to 50% (w/w) at room
temperature, which is considerably greater than that of 9.9 MAG (~40% (w/w)). This indicates that the
cubic mesophase formed by 9.7 MAG has bigger aqueous channels compared to that of 9.9 MAG to
better accommodate the relatively large non-membrane domains (arrestin and T4L) of the fusion protein
and to facilitate the diffusion and crystallization of the fusion protein in the mesophase (Fig. 1b).
For initial LCP crystallization, a well-established protocol was used to reconstitute the T4L-rhodopsin-
arrestin fusion protein into the lipid bilayer of the cubic phase8. Briefly, protein solution of about 30 mg/
ml was mixed with 9.7 MAG containing 10% (w/w) cholesterol at a 1:1 ratio by weight using a coupled
syringe mixer10 until a viscous transparent protein-laden homogenous LCP was formed. The
crystallization was set up using a Gryphon LCP robot (Art Robbins Instruments) or an NT-8 LCP
robot (Formulatrix). A volume of 50 nl boluses of LCP were applied to each well of a 96-well glass
sandwich plate (Molecular Dimensions or Marienfeld-Superior), covered with 0.8 μl crystallization
solutions and sealed with a glass cover slide. The sandwich plates were kept at 20 °C, and multiple initial
hits were identified after a few days from home-made crystallization screens, which were prepared using
30% (v/v) PEG 400 in combination with 100 or 400 mM salts from the StockOptions Salt kit and buffers
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of pH 5, 6, 7, and 8 (refs 9, 12). The final optimized crystals with sizes of 5–20 μm were obtained from a
precipitant containing 28% PEG 400, and 50 mM magnesium acetate, 50 mM sodium acetate at pH 5.0.
These crystals were harvested directly from LCP using MiTeGen loops, frozen in liquid nitrogen and used
for synchrotron data collection (Fig. 2a).
SFX data collection requires tens to hundreds μl of LCP filled with microcrystals at high density. We
therefore used our previously developed protocols to scale-up crystallization set-up using 100 μl gas-tight
Hamilton syringes4,13. Briefly, a volume of 5 μl protein-laden LCP, as used for crystallization in sandwich
plates, was slowly injected as a continuous string into a 100 μl syringe filled with 60 μl of crystallization
solution10. High density microcrystals grew in the mesophase in the syringes over 12 to 24 h at 20 °C. The
best crystals were obtained from the crystallization condition of 32%(v/v) PEG 400, and 150mM
ammonium phosphate at pH 6.4. The crystal sizes were at about 5–10 μm measured using a polarized
light microscope (Fig. 2b). The LCP with crystals was consolidated from several syringes and transferred
into the LCP injector14 for XFEL diffraction data collection.
Synchrotron diffraction data collection and processing
Data sets to about 8.0 Å resolution were collected from multiple crystals (5–10 crystals) using the
21-ID-D beam line of LS-CAT with a Mar 300 CCD detector or 23-ID-D beam line of GM/CA-CAT with
a Pilatus 6M detector at the Advanced Photon Source (APS), Argonne National Laboratory at Argonne,
IL (Fig. 3a). An additional data set to 7.7 Å was collected from a single crystal of about 20 μm size using a
10 μm beam of 1.033 Å wavelength and 0.1 s exposure time per 0.1° oscillation with a Pilatus 6M pixel
detector at a distance of 600 mm at the X10SA beam line of the Swiss Light Source. The diffraction data
were reduced, integrated and scaled with XDS15. The data statistics are shown in Table 1. While the 7.7 Å
Figure 1. The lipidic cubic phase of 9.7 MAG facilitates the crystallization of T4L-rhodopsin-arrestin complex.
(a) Temperature-composition phase diagram of 9.7 MAG/water system. The phase diagram was constructed
based on small- and wide-angle X-ray scattering measurements made in the heating direction. Sample
preparation and X-ray scattering measurements and analysis were as previously described10,11. The phases
observed include the lamellar crystalline (Lc, or solid phase; yellow), the fluid isotropic (FI or liquid phase;
grey), and the following liquid crystalline phases: lamellar liquid crystal (Lα; brown), cubic-Ia3d (green) and
cubic-Pn3m (purple). A separate aqueous phase observed in equilibrium with the solid or liquid crystalline
phases is indicated by Aq. The phase diagram shows that the solid Lc phase stabilizes under equilibrium
conditions below ~8 °C. The latter is some 10 °C below that observed with 9.9 MAG (monoolein)11 and is
similar to what was found with 7.9 MAG36. This low solidification temperature enabled use in the current
project of 9.7 MAG as a host lipid for LCP-SFX data collection in an evacuated sample chamber at 20 °C, where
evaporative cooling created problems for measurements with 9.9 MAG but not with 7.9 MAG14. The maximum
water carrying capacity of 9.7 MAG resides at ~50%(w/w) water which is considerably greater and smaller than
that of 9.9 MAG11, and 7.7 MAG37, respectively. These observations indicate that the cubic mesophase of
9.7 MAG has larger aqueous channels compared to 9.9 MAG that are more like those of 7.7 MAG. This is
consistent with 9.7 MAG supporting the growth of rhodopsin-arrestin-T4L crystals where the complex has
sizable extra-membrane bulk best accommodated in a large aqueous channel. This parallels the observations
made with 7.7 MAG as a host lipid for the β2AR-Gs complex structure determination30. (b) Cartoon
representation of the T4L-rhodopsin-arrestin complex protein (rhodopsin is in blue, arrestin in green, and T4L
is omitted) reconstituted in the LCP of 9.7 MAG, with the rhodopsin embedded in the bilayer of the LCP and
the arrestin accommodated in the aqueous channel. Components of the precipitant solution are proposed
to locally stabilize a lamellar domain into which the protein preferentially partitions from the LCP which acts
as a reservoir. It is in the lamellar domain that nucleation and crystal growth take place (figure adapted
from Li et al.38).
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data set from a single crystal was used for twinning analysis and the validation of the structure model
from SFX data, all other synchrotron data sets were not used for structure determination of the
T4L-rhodopsin-arrestin complex because of their lower resolution.
X-ray free electron laser data collection
The SFX experiments were performed using the LCLS Coherent X-ray Imaging (CXI) instrument at the
SLAC National Accelerator Laboratory (Menlo Park, California, USA). Rhodopsin-arrestin complex
crystals of 5–15 μm in LCP were streamed across the XFEL beam in a continuous mesophase column at a
flow rate of 0.18 μl/min using an LCP injector14 with a 50 μm diameter nozzle. X-ray pulses of 48 fs
duration and 9.5 keV photon energy (1.3 Å wavelength) were focused to a spot of ~1 μm FWHM using
Kirkpatrick-Baez mirrors and centered on the LCP column using an inline microscope. A transmission of
3–10% was used and an average flux of 3 × 1010 photons per pulse was delivered to single crystals in the
LCP column with an estimated maximum dose of about 25 MGy per crystal. Crystals in the LCP stream
were randomly oriented in the interaction region, producing a crystal diffraction pattern whenever the
regular 120 Hz X-ray pulse repetition rate happened to coincide with a crystal being in the focal region.
Diffraction patterns were read out and recorded with a Cornell-SLAC pixel array detector (CSPAD)16 at a
sample-to-detector distance of 100 mm after each X-ray pulse (Fig. 3b and Data Citation 2).
Approximately 100 μl of crystal-laden mesophase was used for data collection.
Three slightly different preparations of rhodopsin-arrestin complex were used: batches 1, 2, and 3,
these were noted internally as Rho-Arr-ATR, Rho-Arr(C234)-ATR, and Rho-Arr(C235)-ATR-IP6,
Figure 2. T4L-rhodopsin-arrestin crystals grown in LCP. (a) T4L-rhodopsin-arrestin crystals in sandwich
plates viewed under bright field illumination (left panel) and polarized light (right panel). (b) Crystals in
syringes under polarized light.
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corresponding to runs 2–50, 52–64 and 69–73, respectively of experiment LE79 at the CXI instrument at
LCLS in November 2014 (Data Citation 2). Even though all three batches were expected to be
isomorphous, we found during data processing that merging data from batches 1+2 (runs 2–64)
produced superior statistics and electron density than merging all three batches (runs 2–73) (Data
Citation 2), despite the smaller number of crystals included in the data set consisting of only batches 1+2
compared to all data. We speculate that this is due to slight non-isomorphism between the different
individual preparation conditions. All data has been deposited with the CXIDB (see the section of ‘Data
records’, and Data Citation 2) even though only data from batches 1+2 were used for the published
structure.
XFEL data processing
About 5 million data frames were recorded in a 10-hour data acquisition period using crystal sample
batch 1+2. The initial data were reduced and analyzed using the program Cheetah17. Of the recorded
frames, 22,262 images were identified containing potential crystal hits with more than 40 Bragg peaks of
Data collection XFEL Synchrotron
PDB code 4ZWJ (Data Citation 1) 5DGY (Data Citation 3)
Wavelength (Å) 1.33 1.03
Space group P212121 P212121
Cell dimensions
a, b, c (Å) 109.2, 109.2, 452.6 107.3, 107.3, 460.3
σ, β, γ (°) 90, 90, 90 90, 90, 90
Resolution (Å) 31.5–3.3 (3.42–3.30)* 30–7.7 (8.1–7.7)
Rsplit or Rmerge (%) 19.1 (58.7) 31.4 (118.8)
SNR or I/σI 4.7 (1.7) 3.79 (1.08)
CC* 0.996 (0.87) 1.00 (0.81)
Completeness (%) 76.3 (6.4) 97.5 (90.8)
Multiplicity 383 (116) 4.68 (4.12)
Table 1. Diffraction data collection and processing. This table was adopted from the Supplementary
Materials of the original paper9 with addition of the statistics of the synchrotron data collected at X10SA
beamline of the Swiss Light Source. *Values in parentheses are for highest-resolution shell.
Figure 3. X-ray diffraction patterns of T4L-rhodopsin-arrestin crystals. (a) A diffraction image of a
T4L-rhodopsin-arrestin crystal collected at LS-CAT of APS. The green ring indicates the position of reflections
at 8.0 Å resolution; (b) an XFEL diffraction image collected at LCLS with two blue rings indicating 3.0 and 4.0
Å resolution reflections, respectively.
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greater than one pixel in size and a signal-to-noise ratio better than 6 after local background subtraction.
This represented a hit rate of about 0.45% (Fig. 3b).
Data has been deposited with the CXIDB as both processed hits and raw data. Hits found by Cheetah
are saved in Cheetah's single-frame HDF5 format with the minimum number of corrections necessary to
make the data useable: specifically, detector dark correction and common mode correction using
Figure 4. X-ray free-electron laser composite diffraction patterns of T4L-rhodopsin-arrestin crystals. The
reflection intensity of the T4L-rhodopsin-arrestin crystals is displayed as 2D maps at the central section
perpendicular to the unit cell c (panel a) and a axes (panel b), respectively. Resolution rings at 10.0, 5.0, and
3.5 Å are shown.
-0.1
0.1
0.3
0.5
0.7
0.9
1.1
0 0.2 0.4 0.6 0.8 1
Observed
Acentric Theory
Perfect Twin
-0.1
0.1
0.3
0.5
0.7
0.9
1.1
0 0.2 0.4 0.6 0.8 1
Observed
Acentric Theory
Perfect Twin
XFEL Data
Synchrotron Data
N
(|L
|)
|L|
N
(|L
|)
|L|
Figure 5. L-test plots of diffraction data. (a) L-test of the XFEL data from T4L-rhodopsin-arrestin crystals, and
(b) L-test of the synchrotron data from a single crystal, both indicating nearly perfect twinning of the crystals.
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unbonded pixels on the cspad detector, with saturated and bad pixels flagged in a separate mask saved
along with the data (saveDetectorCorrected option). We have additionally deposited the raw data for the
whole experiment in the CXIDB enabling the detector correction and hit finding steps to be repeated if
desired. This raw data is deposited in HDF5 format created using LCLS HDF5 file translation in which raw
data is saved using the layout documented in the LCLS online documentation, enabling processing without
the need to install LCLS-specific XTC file readers. A run table is included to aid analysis of the raw data.
Data frames with crystal hits were extracted in HDF5 format for further analysis with the program
package CrystFEL18. These potential crystal hits prior to indexing have been deposited with the CXIDB
(CXIDB ID 32, Data Citation 2) and are the subject of this Data Descriptor. Of the potential crystal hits,
18,874 diffraction patterns were identified and indexed using the program ‘indexamajig’ in the CrystFEL
package with a combination of indexing methods of MOSFLM19, XDS15 and DirAx20. Reflections were
integrated over the three-dimensional reflection profile using ‘process-hkl’ by which the final integrated
Bragg intensities were constructed with partially recorded intensities from single shot diffraction patterns
of randomly oriented single crystals. An integration region radius of two pixels was used to avoid overlaps
with neighboring peaks due to the high spot density resulted from the large unit cell dimensions. All
merged intensities can be visualized by plotting as a precession-style image along the [001] and [100] axes
of the reciprocal space (Fig. 4a,b). The crystals appeared to be tetragonal or very close to tetragonal, with
an apparent reflection condition of l= 4n (n is an integer) for the 00 l reflections and a unit cell of
a= b= 109.2 Å, c= 452.6 Å, and α= β= γ= 90°. The diffraction strength was anisotropic and the data
was truncated using the CrystFEL program ‘get_hkl’ to 3.3 Å along the c* axis and 3.8 Å along the a* and
b* axes based on the correlation coefficient statistics (CC*) of the data21 (Table 1). This anisotropy in
resolution can be seen in the zone axis sections (Fig. 4a,b).
For certain merohedral space groups, an indexing ambiguity arises which results in a ‘computationally
twinned’ dataset when data from many crystals are merged together in serial crystallography17.
An L-test22 performed using Phenix.xtriage23 showed a mean |L| of 0.399, a mean L2 of 0.191 that
suggested the presence of perfect twinning in our XFEL data (Fig. 5a). Several attempts using recently
reported methods24,25 to resolve the indexing ambiguity failed, indicating that the crystals were probably
physically twinned. To confirm that the perfect twinning of the data was due to the physically twinned
crystals, an L-test of the synchrotron data collected from a single crystal was carried out. The L-test
Figure 6. Pseudo symmetries of rhodopsin-arrestin crystal packing. (a) Pseudo-translational symmetry of the
four T4L-rhodopsin-arrestin complex molecules is shown in the asymmetric unit with two of the four
molecules translated by approximately half of the unit cell along the unit cell a and b axes. The unit cell is
shown as a square box. (b) Pseudo-rotational symmetry of T4L-rhodopsin-arrestin complex molecules is
shown in the asymmetric unit, where two of the four molecules can be overlaid by a 180° rotation around the
a/b axis. Crystals with pseudo rotational symmetry are prone to twinning and the data is consistent with
pseudomerohedral twinning of P212121.
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revealed the mean |L| and the mean L2 of the synchrotron data were 0.342 and 0.169, respectively, and the
same twin law as the XFEL data (Fig. 5b), confirming that the perfect twinning of our XFEL data was
indeed due to the twinned crystals, which could be either in a tetragonal space group and merohedrally
twinned, or in an orthorhombic space group and pseudo-merohedrally twinned because of their nearly
identical unit cell axes of a and b and non-crystallographic rotational symmetry26,27. The exact space
group was later determined by Zanuda28.
Structure determination
For structure determination, molecular replacement (MR) was performed using available structural
models of G protein peptide-bound rhodopsin (PDB code 4A4M29), the pre-activated arrestin (PDB
4J2Q5) and T4 lysozyme (PDB 3SN6 (ref. 30)), and the diffraction data that was expanded to Laue group
4/m. MR searches were carried out in all possible space groups of the tetragonal system using the
program Phaser31. Four copies of either rhodopsin or arrestin and three copies of T4L were found in
space group P43 with Z scores greater than 8 for each solution. There is a pseudo-translational symmetry
by ~1/2a and 1/2b, and a pseudo-rotational symmetry nearly parallel to the twin operation (k, h, − l) of
the molecules in the asymmetric units (Fig. 6a,b).
Because of the perfect twinning and the presence of pseudo-symmetry elements, the apparent space
group of a crystal may not be its true space group. We therefore analyzed the data with the structural
model obtained from space group P43 using Zanuda
28 (Table 2), and found that the space group of
P212121 gave the best Z score and free R values, and was more likely the true space group for this data set.
The data was then expanded to the Laue group of mmm and MR solutions were found in space group
Space group Cell (Å) Nmol/asu TFZ Rwork(%) Rfree(%)
P43 a= b= 109.2, c= 452.6 4 23.9 30.7 36.9
P212121 a= b= 109.2, c= 452.6 4 51.7 25.1 31.6
P21 a= b= 109.2, c= 452.6 8 27.8 23.4 31.8
C2 a= b= 109.2, c= 452.6 4 10.0 44.6 47.8
C2 a= b= 154.5, c= 452.6 8 14.5 30.9 35.7
Table 2. Zanuda analysis. This table was adopted from the Supplementary Materials of the original paper9
with addition of the data and model statistics of the synchrotron data.
Refinement XFEL Synchrotron
PDB code 4ZWJ (Data Citation 1) 5DGY (Data Citation 3)
Resolution range (Å) 31.0–3.3 (3.4–3.3)* 30–7.7 (8.1–7.7 )*
No. reflections (all/free set) 62,613/3,098 6630/845
Rwork/Rfree (%) 25.2/29.3 (33.3/40.8)* 28.5/33.5 (30.2/33.7)*
No. atoms
Rhodopsin 10,344 10,344
Arrestin 10,840 10,840
T4L 3,481 3,481
B factors
Wilson 112.0 303
Proteins 159.7 420
R.M.S. deviations
Bond lengths (Å) 0.008 0.008
Bond angles (°) 1.0 1.0
Ramachandran
Favored (%) 96.3 96.3
Outliers (%) 0.0 0.0
Clash Score 1.47 1.53
MolProbity score 1.13 1.14
Table 3. Refinement and model statistics. This table was adopted from the Supplementary Materials of the
original paper9 with addition of the model statistics of the synchrotron data collected at X10SA beamline of the
Swiss Light Source. *Values in parentheses are for highest-resolution shell.
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P212121 with better statistics (Table 2). Those results indicated that the true space group of the crystals
was P212121, and the crystals appeared to be in space group P43 due to the pseudo-merohedral twinning,
caused by the very close a and b axes of the lattice and the non-crystallographic rotational symmetry that
corresponds to the twin operator k,h,− l. This physical twinning, which corresponds to the same
transformation as the only possible indexing ambiguity for these unit cell parameters and space group
assignment, explains why our attempts to resolve the indexing ambiguity did not succeed.
The structural model from MR was initially rebuilt and refined against the XFEL data without the twin
law using COOT32 and Phenix23. Composite omit maps calculated using a Phenix program were used to
guide manual building of the loop regions missing in the original models, and to rebuild misplaced
residues. After many iterated cycles of model building and refinement, the Rfree reduced, but could not be
further improved beyond 36%, which suggested a point to apply twin law for further refinement. Further
fine-tuning refinement was done using the methods of individual position, group B-factor and TLS with
NCS restraints and twin law. The final Rwork was 25.2% and the Rfree was 29.3%, which demonstrated that
the model was correctly built and refined (Table 3). The final model included four copies of rhodopsin-
arrestin complex, two copies of full T4 lysozyme in complex A and D, respectively, and a partial T4
lysozyme molecule (residues 2–12 and 58–161) in complex C. The rhodopsin ligand all-trans retinal was
not built in the model because of weak density.
Structure validation
The structural model from SFX was extensively validated using various independent biochemical and
biophysical methods, including electron microscopy, double electron-electron resonance spectroscopy,
hydrogen-deuterium exchange mass spectrometry, cell-based rhodopsin-arrestin interaction assays, and
site-specific disulfide cross-linking experiments as reported in the original paper9. Here we focus on the
crystallographic validation of the structure. A composite omit map calculated using a Phenix23 program
with simulated-annealing at 3,000 K showed a density of good quality which suggested that the model
was correctly built (Fig. 7). Real space correlation coefficients against a 2mFo-DFc map for each chain of
the model calculated using the EDSTATS program in CCP4 (ref. 33) indicated an overall good fit between
the structural model and the electron density map (Fig. 8a–d). To further validate the structural model
from SFX, we placed the model in the asymmetric unit of the synchrotron data and performed rigid body
and group B-factor refinement with twin law and NCS restraints. The refined model with good R factors
(Rwork= 28.5%, Rfree= 33.5%, Table 3 and Data Citation 3) against the synchrotron data could be
superposed on the XFEL model with only slight difference (Fig. 9), which confirmed that the XFEL data
Figure 7. A simulated-annealing 2Fo-Fc composite omit map. The map was calculated from the
3.8 Å/3.8 Å/ 3.3 Å XFEL data with 3,000 K simulated annealing and was contoured at 1 σ. The simulated-
annealing omit map supports the overall arrangement of the rhodopsin-arrestin complex. The complex
structure is shown with rhodopsin colored in cyan, arrestin in brown and T4L is not shown in the map.
www.nature.com/sdata/
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was as reliable as a synchrotron data set for crystal structure determination. The MolProbity analysis
revealed an all-atom clash score of 1.47, 0.59% rotamer outliers, 100% favorable and allowed
Ramachandran regions, and an overall MolProbity score of 1.13, corresponding to a better than average
model quality compared to those of similar resolution from the PDB database. The structure was also
analyzed using POLYGON in Phenix23, which indicated that the quality of the model statistics was above
average compared with 535 entries of similar resolution in the PDB (Fig. 10).
Data Records
All data records listed in this section are available at the cxi database (Data Citation 2), and are accessible
via web service at http://www.cxidb.org with CXIDB ID 32.
Technical Validation
The technology of serial femtosecond X-ray crystallography using X-ray free electron lasers has been
developed and validated by several pioneer groups1,4,34,35. The crystal structure of the rhodopsin-arrestin
complex determined using the XFEL dataset was extensively validated through multidisciplinary
technologies including HDX, DEER and disulfide crosslinking as described in the original paper9. The
XFEL data was also validated by crystallographic analysis as described in the section of Structure
Validation. These validations support the technical quality of the XFEL dataset to be used for
3-dimentional structure determination.
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Figure 8. The real space correlation coefficients between the structure and a 2mFo-DFc map. The real space
correlation coefficients of all the residues in the model were calculated against a 2mFo-DFc map using the
CCP4 EDSTATS program. Plots a-d are for T4L-rhodopsin-arrestin complexes A, B, C, and D, respectively,
with main chain residues in blue and side chain residues in red.
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Figure 10. POLYGON analysis of the quality statistics of the rhodopsin-arrestin complex structure.
A comparison of the rhodopsin-arrestin complex structure with 535 structures in the PDB at comparable
resolution indicates that the quality of the current structure is equal to or better than most X-ray structures
in the database of similar resolution.
Figure 9. The superposition of the structure models from synchrotron (yellow) and XFEL data (cyan).
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In summary, obtaining the crystal structure of the rhodopsin complex faced many challenges ranging
from protein engineering to formation of a stable protein complex, from crystallization to data collection
and processing, and from structure determination to validation by multiple inter-disciplinary techniques.
The structure determination of the rhodopsin-arrestin complex using XFEL data provides an important
example that demonstrates the great potential of this technology for solving crystal structures of
challenging proteins that do not grow crystals of sufficient size for crystallographic studies using
conventional X-ray sources.
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